FDA Approved: TECVAYLI — Supplemental Application (Janssen Biotech, Inc.)

View source ↗

Summary

FDA approved a supplemental application for TECVAYLI (teclistamab-cqyv) to expand or modify its labeling for the treatment of multiple myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• TECVAYLI (TECLISTAMAB-CQYV)

Snippet

SUPPL AP for TECVAYLI (TECLISTAMAB-CQYV)